Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Dec 23, 2010 (rev. 1)


Celera this week said it has appointed Alfred Merriweather as senior vice president and CFO.

Merriweather previously was executive vice president and CFO at Calypso Medical Technologies. Prior to that, he served as CFO of Monogram Biosciences and its predecessor Aclara Biosciences, until the company was acquired by Laboratory Corporation of America in 2009.

Merriweather has also served as CFO of Symphonix Devices, Lipomatrix, and Laserscope. He also spent several years at Price Waterhouse in London and San Jose, Calif., and holds a BA in economics and MA from the University of Cambridge.

TcLand Expression recently announced the appointment of Peter Payne as its chief business officer and head of US operations.

Prior to this, Payne worked for Quintiles Transnational, where he held various positions managing senior operations and business development in Europe and the US. Most recently, he was VP of corporate development at Quintiles, and was responsible for inking strategic relationships with drug firms, venture capital funds, and other financial institutions.

TcLand Expression is developing personalized medicine companion diagnostics in immune mediated disorders and is clinically validating personalized medicine biomarkers for tolerance in liver transplantation.

The Scan

Study Links Genetic Risk for ADHD With Alzheimer's Disease

A higher polygenic risk score for attention-deficit/hyperactivity disorder is also linked to cognitive decline and Alzheimer's disease, a new study in Molecular Psychiatry finds.

Study Offers Insights Into Role of Structural Variants in Cancer

A new study in Nature using cell lines shows that structural variants can enable oncogene activation.

Computer Model Uses Genetics, Health Data to Predict Mental Disorders

A new model in JAMA Psychiatry finds combining genetic and health record data can predict a mental disorder diagnosis before one is made clinically.

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.